Skip to main content

Merkel Cell Carcinoma clinical trials at UCSF
1 in progress, 0 open to eligible people

  • Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

    Sorry, in progress, not accepting new patients

    This phase II trial studies how well pembrolizumab works in treating patients with Merkel cell cancer that cannot be removed by surgery or controlled with treatment, or has spread to other parts of the body. Pembrolizumab may stimulate the immune system to identify and destroy cancer cells.

    San Francisco, California and other locations

Last updated: